^
    14d
    Concurrent naxitamab and lorlatinib in a patient with refractory high-risk neuroblastoma: a case report. (PubMed, Front Oncol)
    Mild adverse events occurred during the combined immunotherapy, including transient hypotension managed with intravenous fluids and abdominal and leg pain that improved with analgesics. In conclusion, our case showed that combination therapy with naxitamab and lorlatinib may improve long-term outcomes and reduce chemotherapy-related toxicity.
    Journal • IO biomarker
    |
    ALK (Anaplastic lymphoma kinase)
    |
    ALK mutation
    |
    oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel
    |
    Lorbrena (lorlatinib) • Danyelza (naxitamab-gqgk)
    over1year
    Pillar Biosciences announces expansion of NGS commercial partnership with Illumina (PRNewswire)
    "Pillar Biosciences...today announced an expansion of their existing partnership with Illumina, through which a broader portfolio of Pillar's oncoReveal™ NGS panels will now be offered directly by Illumina. Several of Pillar's oncology panels will be available as part of the validated libraries on the MiSeq i100 Series sequencing platform, which launched last week."
    Licensing / partnership
    |
    OncoReveal™ BRCA1 & BRCA2 plus CNV Panel • OncoReveal™ Myeloid Panel • oncoReveal™ Core LBx • oncoReveal™ Fusion LBx Panel • oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel • oncoReveal™ Solid Tumor v2 Panel
    over2years
    Beckman Coulter Life Sciences and Pillar Biosciences announce NGS application development pipeline for the Biomek NGeniuS System (Pillar Biosciences Press Release)
    "Beckman Coulter Life Sciences...announces a collaboration agreement with Pillar Biosciences, which develops and distributes IVD & RUO NGS testing solutions based on their proprietary SLIMamp® technology to help localize patient testing and optimize the selection of precision therapies for cancer patients...The application development partnership is initially focused on five commercially-available, solid tumor liquid biopsy and hematology panels from Pillar Biosciences..."
    Licensing / partnership
    |
    OncoReveal™ Solid Tumor Panel • oncoReveal™ Core LBx • oncoReveal™ Multi-Cancer with CNV & RNA Fusion Panel • oncoReveal™ Solid Tumor v2 Panel